Navigation Links
Flo-Mist™ Continuous Medication Nebulizer (CMN)

ProductsFlo-Mist™ Continuous Medication Nebulizer (CMN)
Company DHD Healthcare
Item Flo-Mist™ Continuous Medication Nebulizer (CMN)
Features 
  • Auxiliary port --Allows the clinician to add an auxiliary gas flow without recalculating the medication.
  • Rescue Valve --Located in the non-rebreather circuit, a fail-safe one-way valve in the valved Y piece that allows the patient to entrain ambient air should their inspiratory demand exceed the system.
  • Connects directly to flowmeter --Once connected to the flowmeter, Flo-Mist is fully secured and easy to access for refilling.
  • Up to 8 hours of continuous therapy --Flo-Mist delivers medications as well as humidification for any prescribed length of time up to 8 hours.
  • Dosing chart included --Convenient dosing chart included in each package for quick reference.
  • Aerosol and non-rebreather kits --A fast and convenient way to administer therapy in emergency care settings.
  • Standard 22mm aerosol port --Use your existing tubing or purchase Flo-Mist as a kit.
  • Colorful graphics and gradients --Easy to read gradient lines calibrated at 5ml, ensuring precise medication delivery.
Description For delivery of medication as well as humidification, try Flo-Mist™.

Flo-Mist™, is a refillable, closed dilution, high volume, continuous medication nebulizer (CMN), engineered to deliver deep inhalation therapy to patients. Its 200 ml reservoir and jet flow design allow for up to 8 hours of nebulized medication delivery at 25 ml/hr. Particles are delivered within the 3 to 5 micron range. Flo-Mist™ is the product of choice for many different applications.

Flo-Mist's smart design allows clinicians to add an auxiliary flow of air, Oxygen or Heliox through the side port, without the hassle of recalculating the medication dosage.

The versatile Flo-Mist™ is available as a single nebulizer or in aerosol and non-rebreathing mask kits, where everything required for an acute treatment is packaged in one convenient kit.

For patients requiring higher concentrations (> 50%) of oxygen, consider Flo-Mist's non-rebreathing mask kit. Designed to allow Oxygen and Heliox delivery to be controlled, it can safely provide patients with the gas concentrations they need. This kit, complete with built-in rescue valve and reservoir bag, allows the patient to entrain room air should the patient's inspiratory demand exceed the system.

Shipped 10 kits per case.

Not licensed for sale in Canada.
Info 

Related medicine products :

1. Flo-Mist™ Continuous Medication Nebulizer (CMN) - Adult Kits
2. Flo-Mist™ Continuous Medication Nebulizer (CMN) - Pediatric Kits
3. CGMS System Gold Continuous Glucose Monitoring
4. Continuous Wave II Arthroscopy Pump
5. DNA Engine Opticon Continuous Fluorescence Detection System
6. DNA Engine Opticon 2 Continuous Fluorescence Detection System
7. USA Elite System™ Rotating Continuous Flow Resectoscopes
8. Continuous Flow Cystoscopes
9. CAVR (Continuous Arteriovenous Rewarming)
10. OMNI~MAX Heliox Rescue Continuous Nebulizer
11. DexCom™ STS™ Continuous Glucose Monitoring System
Trilogy Pacemakers incorporates the clinically proven Omniscence™ accelerometer sensor with it's automatic alogorithms. The Trilogy family of pacemakers feature an array of products for bradyar...
The Regency family of pacemakers offers advanced, easy-to-use rate-responsive and nonrate-responsive devices....
... ADx pacemaker family, which ... dual-chamber pacemaker, provides clinicians ... including the revolutionary AF ... U.S. commercially approved algorithm ...
... ADx pacemaker family, which includes ... provides clinicians with the most ... the revolutionary AF Suppression™ algorithm, ... commercially approved algorithm designed to ...
Medicine Products:
(Date:9/18/2014)... Rochelle, NY, September 18, 2014An Emergency Room Decision-Support ... hospital admissions among older adults on Medicare. This ... the nearly 33% of avoidable ER visits that ... costs each year. Details of a successful ERDS ... are published in an article in Population ...
(Date:9/18/2014)... It is almost time to park your Hyundai to ... happier kids. The South Florida Hyundai Dealers Association is ... Children’s Hospital 5K Run/Walk. Its title sponsor is Hyundai ... 5K will take place on Saturday August 20th. The ... City Hall located at 405 Biltmore Way. Registration is ...
(Date:9/18/2014)... Clinical trial report, “Edema Global Clinical Trials ... trial scenario. This report provides elemental information and data ... an overview of the trial numbers and their recruitment ... the globe. The databook offers a preliminary coverage of ... of the sponsors and also provides briefing pertaining to ...
(Date:9/18/2014)... September 18, 2014 Good Neighbor ... launch of Good Neighbor Pharmacy University, an online ... that will educate and empower pharmacy owners and ... healthcare industry continues to evolve, Good Neighbor Pharmacy ... deliver resources and tools to help their businesses ...
(Date:9/18/2014)... 18, 2014 CD-adapco, the largest privately ... today announced its new partnership with Ben Ainslie Racing. ... simulation tool, STAR-CCM+® in the design of its racing ... in the 35th America’s Cup taking place in 2017. ... America’s Cup is sustainability, the set of restrictive rules ...
Breaking Medicine News(10 mins):Health News:Decision-support program helps keep seniors out of the emergency room 2Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 2Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 2Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 4Health News:Good Neighbor Pharmacy University Keeps Pharmacists Ahead of the Curve 2Health News:Ben Ainslie Racing Using STAR-CCM+ Simulation Software to Design 35th America’s Cup Racing Boat 2
... anti-HLA antibody assays both contribute to characterization ... ... immunosuppression, COLUMBIA, Md., June 1 Data developed by Cylex ... the American Transplantation Congress in Toronto, Canada, suggest,that cell-mediated immunity and ...
... also helped with severe fatigue among patients on chemotherapy ... the more common and unpleasant side effects of treatment ... by the ancient Chinese practice of acupuncture. , A ... and pain and shoulder dysfunction after neck dissection in ...
... treatment of choice for advanced, metastatic prostate cancer has ... testosterone the hormone that fuels prostate-cancer growth ... drugs. While such therapy buys time for patients, it ... resistant to the androgen deprivation and continues to grow. ...
... VA Three new studies published in the June ... focus on what role gender plays in the prognosis ... and the success rates of hearing aid implants in ... the wide variety of critical research being undertaken every ...
... pancreatic, kidney cancers, respectively , , SATURDAY, May ... cancer -- which historically carries a grim prognosis ... cancer drug Gemzar was used after surgery, new ... of pancreatic cancer patients are even candidates for ...
... death for female survivors; cardiovascular events for males ... survived Hodgkin lymphoma as children have an increased risk ... disease as adults, according to a new report. ... -- may help drive these increased risks, according to ...
Cached Medicine News:Health News:Cell-Mediated Immunity and Anti-HLA Antibody Tests Provide Insight to Immune Response in Renal Transplant Patients 2Health News:Cell-Mediated Immunity and Anti-HLA Antibody Tests Provide Insight to Immune Response in Renal Transplant Patients 3Health News:Acupuncture Eases Side Effects of Head, Neck Cancer Treatments 2Health News:Acupuncture Eases Side Effects of Head, Neck Cancer Treatments 3Health News:How advanced prostate cancer becomes resistant to androgen-deprivation therapy 2Health News:How advanced prostate cancer becomes resistant to androgen-deprivation therapy 3Health News:New research offers insight into oral cancer, chronic pediatric ear infections, and hearing health 2Health News:New Hope for Tough-to-Treat Cancers 2Health News:New Hope for Tough-to-Treat Cancers 3Health News:Hodgkin Lymphoma Kids Face Greater Risk of Future Problems 2
(Date:9/18/2014)... YORK , Sept. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced today ... to the position of  Senior Director of Clinical ... Research, Mr. James has established and led successful global ... Europe , to facilitate the clinical development of ...
(Date:9/18/2014)... JOLLA, Calif. , Sept. 18, 2014 /PRNewswire/ ... RGLS ), a biopharmaceutical company leading the discovery ... today it has initiated its ATHENA natural history ... a life-threatening genetic kidney disease with no approved ... the natural decline of renal function markers such ...
(Date:9/18/2014)... and ROCKVILLE, Md. , Sept. 18, ... ), a biotechnology company with fully integrated commercial and ... and oncology, and CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a primary focus on China , ...
Breaking Medicine Technology:Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 4Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 5Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 6Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 2Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 3Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 4Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 5Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 6Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 7Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 8Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 9Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 10